OriGene品牌怎么样 申请店铺

Origene, founded in 1996, is based on the collection of the world's largest human full-length cDNA clone library, which is constructed in a unified expression vector, and commercialized as a research tool for scientists around the world. With the completion of human genome sequencing and the development of research tools based on genome research, people can identify drug-related targets through the research of system biology. Origene aims to provide a large number of research tools and technology platforms such as genome, proteome, antibody, etc., so that scientists can study the whole biological pathway, so as to have a deeper understanding of the mechanism of disease, such as cancer, stem cell research, etc. Origene uses high-throughput genomic technology to provide high-performance products for pharmaceutical, biotechnology and basic research workers. The company's flagship product is the world's largest cDNA clone library: trueclonetmcdna clone covering more than 38000 full-length genes and more than 31000 trueorftmcdna clones. Using trueorft mcdna cloning, the company has developed a large number of full-length human recombinant protein products (mammalian cell expression), which can be used for protein function research. In 2010, origene launched the truemab project to develop mouse monoclonal antibodies with full-length human recombinant proteins as antigens. The goal is to develop a protein detection reagent for each human protein. In August 2010, origene acquired blueheron biotechnology. Now, the company can provide you with a complete molecular biology service scheme from codon optimization, gene synthesis, protein expression to detection and development. In 2011, origene acquired Beijing Zhongshan Jinqiao Biotechnology Co., Ltd., and its products began to enter the clinical pathology market. In 2013, origene acquired sdix's life sciences business. Consolidate the leading position in antibody R & D and production, and better meet the needs of customers in antibody and detection products. Beijing Aorui Dongyuan Biotechnology Co., Ltd. is a wholly-owned subsidiary invested and built by origene in China, which is responsible for handling all business of origene in China. The company focuses on providing excellent products and timely and thoughtful services for domestic life science workers, through a wealth of gene, protein, antibody, analysis kit and other product lines.

本文链接： https://brand.waitui.com/537e434c2.html 联系电话：400-6744-363,010-59755312